Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tifcemalimab (TAB004)
i
Other names:
TAB004, JS004, JS 004, JS-004, TAB 004, TAB-004
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Shanghai Junshi Biosci
Drug class:
BTLA inhibitor
Related drugs:
‹
HFB200603 (0)
HFB200603 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CD8 expression
Solid Tumor
CD8 expression
Solid Tumor
TAB004
Sensitive: C3 – Early Trials
TAB004
Sensitive
:
C3
TAB004
Sensitive: C3 – Early Trials
TAB004
Sensitive
:
C3
TNFRSF14 expression
Solid Tumor
TNFRSF14 expression
Solid Tumor
TAB004
Sensitive: C3 – Early Trials
TAB004
Sensitive
:
C3
TAB004
Sensitive: C3 – Early Trials
TAB004
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login